Open AccessIntermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis
Author(s) -
Federico Piñero,
Sebastián Marciano,
Nora Fernández,
Jorge Silva,
Margarita Anders,
Alina Zerega,
Ezequiel Ridruejo,
Gustavo Romero,
Beatriz Ameigeiras,
Claudia D’Amico,
Luis Gaite,
Carla Bermúdez,
Virginia Reggiardo,
Luis Colombato,
Adrián Gadano,
Marcelo Silva
Publication year - 2019
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v25.i27.3607
Subject(s) - hepatocellular carcinoma , hazard ratio , medicine , sorafenib , liver cancer , proportional hazards model , gastroenterology , confidence interval , stage (stratigraphy) , oncology , biology , paleontology
Hepatocellular carcinoma (HCC) represents the sixteenth most frequent cancer in Argentina. The rise of new therapeutic modalities in intermediate-advanced HCC opens up a new paradigm for the treatment of HCC.